- Home
- JKHY vs MEDP Comparison
JKHY vs MEDP Comparison
Compare JKHY & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JKHY
- MEDP
- Stock Information
- Founded
- JKHY 1976
- MEDP 1992
- Country
- JKHY United States
- MEDP United States
- Employees
- JKHY N/A
- MEDP N/A
- Industry
- JKHY Retail: Computer Software & Peripheral Equipment
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- JKHY Technology
- MEDP Health Care
- Exchange
- JKHY Nasdaq
- MEDP Nasdaq
- Market Cap
- JKHY 12.6B
- MEDP 13.4B
- IPO Year
- JKHY N/A
- MEDP 2016
- Fundamental
- Price
- JKHY $149.46
- MEDP $531.00
- Analyst Decision
- JKHY Hold
- MEDP Hold
- Analyst Count
- JKHY 8
- MEDP 11
- Target Price
- JKHY $180.88
- MEDP $421.60
- AVG Volume (30 Days)
- JKHY 1.2M
- MEDP 296.6K
- Earning Date
- JKHY 11-04-2025
- MEDP 10-22-2025
- Dividend Yield
- JKHY 1.54%
- MEDP N/A
- EPS Growth
- JKHY 19.31
- MEDP 26.42
- EPS
- JKHY 6.24
- MEDP 13.46
- Revenue
- JKHY $2,375,288,000.00
- MEDP $2,231,787,000.00
- Revenue This Year
- JKHY $6.98
- MEDP $19.06
- Revenue Next Year
- JKHY $6.41
- MEDP $8.64
- P/E Ratio
- JKHY $24.13
- MEDP $39.46
- Revenue Growth
- JKHY 7.21
- MEDP 9.94
- 52 Week Low
- JKHY $144.12
- MEDP $250.05
- 52 Week High
- JKHY $196.00
- MEDP $547.15
- Technical
- Relative Strength Index (RSI)
- JKHY 36.79
- MEDP 69.72
- Support Level
- JKHY $144.13
- MEDP $524.32
- Resistance Level
- JKHY $151.81
- MEDP $538.32
- Average True Range (ATR)
- JKHY 2.64
- MEDP 13.01
- MACD
- JKHY 0.15
- MEDP 0.57
- Stochastic Oscillator
- JKHY 39.35
- MEDP 76.71
About JKHY Jack Henry & Associates Inc.
Jack Henry is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing for US banks and credit unions, with a focus on small and midsize banks. Jack Henry serves almost 1,000 banks and over 700 credit unions.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.